A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

  1. Verónica Rey
  2. Juan Tornín
  3. Juan Jose Alba-Linares
  4. Cristina Robledo
  5. Dzohara Murillo
  6. Aida Rodríguez
  7. Borja Gallego
  8. Carmen Huergo
  9. Cristina Viera
  10. Alejandro Braña
  11. Aurora Astudillo
  12. Dominique Heymann
  13. Karoly Szuhai
  14. Judith V.M.G. Bovée
  15. Agustín F. Fernández
  16. Mario F. Fraga
  17. Javier Alonso
  18. René Rodríguez
Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.ebiom.2024.105090
  2. Version published to 10.1101/2023.09.12.557334v1 on bioRxiv